450 related articles for article (PubMed ID: 12767733)
1. Oral topiramate for treatment of alcohol dependence: a randomised controlled trial.
Johnson BA; Ait-Daoud N; Bowden CL; DiClemente CC; Roache JD; Lawson K; Javors MA; Ma JZ
Lancet; 2003 May; 361(9370):1677-85. PubMed ID: 12767733
[TBL] [Abstract][Full Text] [Related]
2. Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial.
Johnson BA; Ait-Daoud N; Akhtar FZ; Ma JZ
Arch Gen Psychiatry; 2004 Sep; 61(9):905-12. PubMed ID: 15351769
[TBL] [Abstract][Full Text] [Related]
3. Topiramate for treating alcohol dependence: a randomized controlled trial.
Johnson BA; Rosenthal N; Capece JA; Wiegand F; Mao L; Beyers K; McKay A; Ait-Daoud N; Anton RF; Ciraulo DA; Kranzler HR; Mann K; O'Malley SS; Swift RM; ;
JAMA; 2007 Oct; 298(14):1641-51. PubMed ID: 17925516
[TBL] [Abstract][Full Text] [Related]
4. Use of oral topiramate to promote smoking abstinence among alcohol-dependent smokers: a randomized controlled trial.
Johnson BA; Ait-Daoud N; Akhtar FZ; Javors MA
Arch Intern Med; 2005 Jul; 165(14):1600-5. PubMed ID: 16043677
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME
Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
[TBL] [Abstract][Full Text] [Related]
6. Topiramate reduces the harm of excessive drinking: implications for public health and primary care.
Ma JZ; Ait-Daoud N; Johnson BA
Addiction; 2006 Nov; 101(11):1561-8. PubMed ID: 17034435
[TBL] [Abstract][Full Text] [Related]
7. Topiramate treatment for alcoholic outpatients recently receiving residential treatment programs: a 12-week, randomized, placebo-controlled trial.
Likhitsathian S; Uttawichai K; Booncharoen H; Wittayanookulluk A; Angkurawaranon C; Srisurapanont M
Drug Alcohol Depend; 2013 Dec; 133(2):440-6. PubMed ID: 23906999
[TBL] [Abstract][Full Text] [Related]
8. A pilot double-blind treatment trial of memantine for alcohol dependence.
Evans SM; Levin FR; Brooks DJ; Garawi F
Alcohol Clin Exp Res; 2007 May; 31(5):775-82. PubMed ID: 17378918
[TBL] [Abstract][Full Text] [Related]
9. Topiramate versus naltrexone for alcohol use disorder: study protocol for a genotype-stratified, double-blind randomised controlled trial (TOP study).
Morley KC; Kranzler HR; Luquin N; Baillie A; Shanahan M; Trent R; Teesson M; Haber PS
Trials; 2018 Aug; 19(1):443. PubMed ID: 30115121
[TBL] [Abstract][Full Text] [Related]
10. Comparing topiramate with naltrexone in the treatment of alcohol dependence.
Baltieri DA; Daró FR; Ribeiro PL; de Andrade AG
Addiction; 2008 Dec; 103(12):2035-44. PubMed ID: 18855810
[TBL] [Abstract][Full Text] [Related]
11. Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial.
Johnson BA; Rosenthal N; Capece JA; Wiegand F; Mao L; Beyers K; McKay A; Ait-Daoud N; Addolorato G; Anton RF; Ciraulo DA; Kranzler HR; Mann K; O'Malley SS; Swift RM; ;
Arch Intern Med; 2008 Jun; 168(11):1188-99. PubMed ID: 18541827
[TBL] [Abstract][Full Text] [Related]
12. A phase 2, placebo-controlled study of the opioid receptor antagonist LY2196044 for the treatment of alcohol dependence.
Wong CJ; Witcher J; Mallinckrodt C; Dean RA; Anton RF; Chen Y; Fijal BA; Ouyang H; Dharia S; Sundseth SS; Schuh KJ; Kinon BJ
Alcohol Clin Exp Res; 2014 Feb; 38(2):511-20. PubMed ID: 24010675
[TBL] [Abstract][Full Text] [Related]
13. Topiramate Versus Naltrexone for Alcohol Use Disorder: A Genotype-Stratified Double-Blind Randomized Controlled Trial.
Morley KC; Kranzler HR; Luquin N; Jamshidi N; Adams C; Montebello M; Tremonti C; Dali G; Logge W; Baillie A; Teesson M; Trent R; Haber PS
Am J Psychiatry; 2024 May; 181(5):403-411. PubMed ID: 38706338
[TBL] [Abstract][Full Text] [Related]
14. Topiramate as add-on therapy in non-respondent alcohol dependant patients: a 12 month follow-up study.
Fernandez Miranda JJ; Marina González PA; Montes Pérez M; Díaz González T; Gutierrez Cienfuegos E; Antuña Díaz MJ; Bobes García J
Actas Esp Psiquiatr; 2007; 35(4):236-42. PubMed ID: 17592785
[TBL] [Abstract][Full Text] [Related]
15. Comparing and Combining Topiramate and Aripiprazole on Alcohol-Related Outcomes in a Human Laboratory Study.
Haass-Koffler CL; Goodyear K; Zywiak WH; Leggio L; Kenna GA; Swift RM
Alcohol Alcohol; 2018 May; 53(3):268-276. PubMed ID: 29281033
[TBL] [Abstract][Full Text] [Related]
16. Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial.
Diener HC; Agosti R; Allais G; Bergmans P; Bussone G; Davies B; Ertas M; Lanteri-Minet M; Reuter U; Sánchez Del Río M; Schoenen J; Schwalen S; van Oene J;
Lancet Neurol; 2007 Dec; 6(12):1054-62. PubMed ID: 17988947
[TBL] [Abstract][Full Text] [Related]
17. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
[TBL] [Abstract][Full Text] [Related]
18. Effects of acute topiramate dosing on methamphetamine-induced subjective mood.
Johnson BA; Roache JD; Ait-Daoud N; Wells LT; Wallace CL; Dawes MA; Liu L; Wang XQ
Int J Neuropsychopharmacol; 2007 Feb; 10(1):85-98. PubMed ID: 16448579
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence.
Kampman KM; Pettinati HM; Lynch KG; Spratt K; Wierzbicki MR; O'Brien CP
Drug Alcohol Depend; 2013 Nov; 133(1):94-9. PubMed ID: 23810644
[TBL] [Abstract][Full Text] [Related]
20. A Randomized Trial Evaluating Whether Topiramate Aids Smoking Cessation and Prevents Alcohol Relapse in Recovering Alcohol-Dependent Men.
Anthenelli RM; Heffner JL; Wong E; Tibbs J; Russell K; Isgro M; Dinh E; Wehrle C; Worley MJ; Doran N
Alcohol Clin Exp Res; 2017 Jan; 41(1):197-206. PubMed ID: 28029173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
